Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non Operating Income: 2015-2024

Historic Non Operating Income for Viridian Therapeutics, Inc.\DE (VRDN) over the last 10 years, with Dec 2024 value amounting to $29.1 million.

  • Viridian Therapeutics, Inc.\DE's Non Operating Income fell 20.28% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 0.73%. This contributed to the annual value of $29.1 million for FY2024, which is 74.00% up from last year.
  • As of FY2024, Viridian Therapeutics, Inc.\DE's Non Operating Income stood at $29.1 million, which was up 74.00% from $16.7 million recorded in FY2023.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Non Operating Income ranged from a high of $29.1 million in FY2024 and a low of $173,000 during FY2020.
  • Moreover, its 3-year median value for Non Operating Income was $16.7 million (2023), whereas its average is $16.7 million.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Non Operating Income slumped by 81.62% in 2020 and then spiked by 1,306.35% in 2022.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Non Operating Income (Yearly) stood at $173,000 in 2020, then soared by 82.08% to $315,000 in 2021, then soared by 1,306.35% to $4.4 million in 2022, then soared by 277.34% to $16.7 million in 2023, then soared by 74.00% to $29.1 million in 2024.